ALK and neoplasm: Subsequent investigations demonstrated that inhibiting YAP1 genetically or pharmacologically suppressed tumor growth in ALK-TKI-resistant lung adenocarcinoma cells, EML4-ALK transgenic mice, and tumor xenograft models.